A 12-month follow-up split-scalp study comparing calcipotriol-assisted MAL-PDT with conventional MAL-PDT for the treatment of actinic keratosis: a randomized controlled trial
暂无分享,去创建一个
[1] M. Wallendorf,et al. Skin cancer precursor immunotherapy for squamous cell carcinoma prevention. , 2019, JCI insight.
[2] M. Haedersdal,et al. A randomized split‐scalp study comparing calcipotriol‐assisted methyl aminolaevulinate photodynamic therapy (MAL‐PDT) with conventional MAL‐PDT for the treatment of actinic keratosis , 2018, The British journal of dermatology.
[3] C. Morton,et al. Daylight Photodynamic Therapy for Actinic Keratoses , 2018, American Journal of Clinical Dermatology.
[4] K. Peris,et al. Structured Expert Consensus on Actinic Keratosis: Treatment Algorithm Focusing on Daylight PDT , 2017, Journal of cutaneous medicine and surgery.
[5] M. Wallendorf,et al. Randomized trial of calcipotriol combined with 5-fluorouracil for skin cancer precursor immunotherapy , 2017, The Journal of clinical investigation.
[6] H. Wulf,et al. Short‐term chemical pretreatment cannot replace curettage in photodynamic therapy , 2016, Photodermatology, photoimmunology & photomedicine.
[7] S. Shumack,et al. Evidence‐ and consensus‐based (S3) Guidelines for the Treatment of Actinic Keratosis – International League of Dermatological Societies in cooperation with the European Dermatology Forum – Short version , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.
[8] Sanjay Anand,et al. Topical calcitriol prior to photodynamic therapy enhances treatment efficacy in non-melanoma skin cancer mouse models , 2015, Photonics West - Biomedical Optics.
[9] H. Wulf,et al. Calcipotriol pretreatment enhances methyl aminolevulinate‐induced protoporphyrin IX: an in vivo study in hairless mice , 2015, Photodermatology, photoimmunology & photomedicine.
[10] C. Chiang,et al. Improve efficacy of topical ALA-PDT by calcipotriol through up-regulation of coproporphyrinogen oxidase. , 2014, Photodiagnosis and photodynamic therapy.
[11] A. Sidoroff,et al. European guidelines for topical photodynamic therapy part 1: treatment delivery and current indications – actinic keratoses, Bowen’s disease, basal cell carcinoma , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.
[12] S Schreml,et al. Clinical, histopathological and immunohistochemical assessment of human skin field cancerization before and after photodynamic therapy , 2012, The British journal of dermatology.
[13] T. Hasan,et al. Vitamin D3 enhances the apoptotic response of epithelial tumors to aminolevulinate-based photodynamic therapy. , 2011, Cancer research.
[14] A. Hauschild,et al. Long‐term follow‐up of photodynamic therapy with a self‐adhesive 5‐aminolaevulinic acid patch: 12 months data , 2010, The British journal of dermatology.
[15] P. van Erp,et al. Pretreatment to Enhance Protoporphyrin IX Accumulation in Photodynamic Therapy , 2008, Dermatology.
[16] T. Hasan,et al. Differentiation-specific increase in ALA-induced protoporphyrin IX accumulation in primary mouse keratinocytes. , 1998, British Journal of Cancer.
[17] J. Callen,et al. A double-blind, vehicle-controlled study evaluating masoprocol cream in the treatment of actinic keratoses on the head and neck. , 1991, Journal of the American Academy of Dermatology.
[18] F. D. de Gruijl,et al. UV-induced epidermal hyperplasia in hairless mice. , 1986, Photo-dermatology.
[19] C. Lerche,et al. Skin tumor development after UV irradiation and photodynamic therapy is unaffected by short-term pretreatment with 5-fluorouracil, imiquimod and calcipotriol. An experimental hairless mouse study. , 2016, Journal of photochemistry and photobiology. B, Biology.
[20] M. Thissen,et al. Actinic keratosis: how to differentiate the good from the bad ones? , 2006, European journal of dermatology : EJD.
[21] J. Jensen,et al. Topical vitamin D3 derivatives impair the epidermal permeability barrier in normal mouse skin. , 1997, Dermatology.